Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to evaluate the performance of Modulated Imaging Inc.'s (MI) next generation Spatial Frequency Domain Imaging (SFDI) system to measure potential circulatory compromise.


Clinical Trial Description

The objective of this study is to demonstrate the performance of Modulated Imaging Inc.'s (MI) next generation Spatial Frequency Domain Imaging (SFDI) system, "The Ox-Imager Mini". Potential circulatory compromise will be imaged in healthy volunteers using both the subject and predicate devices (Ox-Imager CS) in a Vascular Occlusion Test (VOT) model. The VOT model is an established paradigm to introduce transient ischemia in skin and the the subjects will be imaged during this time. The primary endpoint will be to measure significant decrease in tissue oxygen saturation after occlusion for both predicate and subject devices. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03563105
Study type Interventional
Source Modulated Imaging Inc.
Contact
Status Active, not recruiting
Phase N/A
Start date May 30, 2018
Completion date May 1, 2019

See also
  Status Clinical Trial Phase
Completed NCT01417754 - Changes in Breast 3D Ultrasound Measurements Using Toremifene Phase 3
Completed NCT03371537 - Study of Hemodynamic Conditions Measured During Hepatectomy
Completed NCT02727829 - The Assessment of Microcirculation in Brachial Plexus Block Using Perfusion Index and Capillary Filling Time N/A
Recruiting NCT05302219 - Plethysmography Curve Variability Depending on the Breath Cycle N/A
Not yet recruiting NCT06440252 - Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults Phase 3
Completed NCT03724162 - Evaluation of the Circulatory Status of Stomach Tube and Gastrooesophageal Anastomosis
Completed NCT03023488 - Effects of Flexible Ureteroscopy on Renal Blood Flow N/A
Not yet recruiting NCT04630704 - Evaluating A Non-Invasive Tissue Perfusion Monitor